NIQUITIN 21 mg/24 hours, medicated transdermal patch CIP 3400930260432
Active ingredients: NICOTINE
Commercialized according to BDPM
Medicated transdermal patchCIP 3400930260432transdermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NIQUITIN 21 mg/24 heures, dispositif transdermique
- Pharmaceutical form
- dispositif
- Route of administration
- transdermique
- Presentation description
- 28 dispositif(s) en sachet(s) polytéréphtalate (PET) polyéthylène aluminium EVOH : éthylène alcool vinylique
- Marketing authorisation holder
- LABORATOIRE PERRIGO FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Jan 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61056501CIP73026043CIP133400930260432Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NICOTINEdispositif | 114 mg · un dispositif transdermique de 22 cm^^2 | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.